InsidersTradesSigma
Track the 박셀바이오 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 박셀바이오 has recorded 2 reports. Market capitalisation: €94.3bn. The latest transaction was disclosed on 27 March 2026 (Purchase). Among the most active insiders: 이제중. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
박셀바이오 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative therapies and biological solutions.